We are live on ! Find out more
CATX icon

Perspective Therapeutics

48 hedge funds and large institutions have $13.9M invested in Perspective Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 1.31%1.23% (-0.08%)

16% less funds holding

Funds holding: 5748 (-9)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

31% less capital invested

Capital invested by funds: $20.2M → $13.9M (-$6.32M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
48
Holders Change
-9
Holders Change %
-15.79%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
11
Closed
17
Calls
Puts
Net Calls
Net Calls Change

CATX Hedge Fund Activity: Q2 2021 in Review

48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2021, worth a combined $13.9M — down 31% from $20.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CATX and 8 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was State Street, adding an estimated $445K. The largest seller was Renaissance Technologies, cutting an estimated $595K.

  • 48 institutional investors held Perspective Therapeutics (CATX) as of Q2 2021, down from 57 in Q1 2021.
  • Funds reported $13.9M of Perspective Therapeutics stock for Q2 2021, down 31% quarter-over-quarter.
  • 8 funds opened new Perspective Therapeutics positions in Q2 2021 and 17 closed out, a net change of -9 holders.
  • The largest Perspective Therapeutics buyer in Q2 2021 was State Street, an estimated $445K added.
  • The largest Perspective Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $595K sold.

Based on aggregated 13F filings for Q2 2021.